HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Unichem Laboratories Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 66 filings·Updated 13 Oct 2026
Showing 10 of 66 filings.
13 Oct 20262 filings
Company UpdateCertificate under SEBI (Depositories and Participants) Regulations, 2018

Unichem Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:11View Source
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance confirms dematerialisation processing, listing, and depository substitution

Dematerialisation processing and listing

  • Dematerialisation requests processed; securities confirmed to depositories (accepted/rejected).
  • Dematerialised securities have been listed on exchanges where the earlier issues are listed.
  • Physical certificates for dematerialisation were mutilated and cancelled after verification; depository name substituted as registered owner within timelines.
Filed 17:05View Source
26 Sept 20262 filings
Company UpdateGeneral

USFDA inspection at Goa facility yields five observations; response within 15 days

USFDA inspection update

  • USFDA inspected the Goa Formulation facility at Pilerne, Bardez from Sep 21 to Sep 26, 2026.
  • The inspection yielded five observations related to procedural enhancements.
  • Unichem will submit responses to USFDA within 15 days.
Filed 17:04View Source
Company UpdateGeneral

US FDA inspection at Unichem Goa facility yields five observations; response due within 15 days

Regulatory update

  • US FDA directed inspection at Goa Formulation facility, Pilerne, Bardez from 21–26 September 2026.
  • Five observations identified relating to procedural enhancements.
  • Intimation filed under Regulation 30 of SEBI LODR.
  • Company to submit its response within 15 days.
Filed 16:57View Source
24 Sept 20262 filings
Insider Trading / SASTClosure of Trading Window

Unichem Laboratories Limited trading window closure from October 1, 2026; shall open 48 (forty-eight) hours after the unaudited financial results for the quarter and half year ended September 30, 2026, are made public.

Unichem Laboratories Limited trading window closure from October 1, 2026; shall open 48 (forty-eight) hours after the unaudited financial results for the quarter and half year ended September 30, 2026, are made public.

Filed 16:31View Source
Insider Trading / SASTClosure of Trading Window

Unichem Laboratories Limited: Trading Window Closed from October 1, 2026; to reopen 48 hours after the unaudited financial results for the quarter and half year ended September 30, 2026 are made public.

Unichem Laboratories Limited: Trading Window Closed from October 1, 2026; to reopen 48 hours after the unaudited financial results for the quarter and half year ended September 30, 2026 are made public.

Filed 16:14View Source
19 Sept 20261 filing
Company UpdateAction(s) taken or orders passed

Unichem Laboratories Receives Order-In-Appeal from Commissioner (Appeals Thane); penalties disallowed

Regulatory Update

  • Order-in-Appeal received from Commissioner (Appeals Thane) on 18 September 2026 after 2:00 PM.
  • Appeal filed; penalties Rs 87,07,09,556 and interest Rs 6,58,76,590 disallowed.
  • Delayed tax payment led to non-payment of interest.
  • Company will appeal within timelines; no material impact expected.
Filed 11:30View Source
11 Sept 20261 filing
Company UpdateGeneral

Unichem Laboratories extends ESOP exercise window for two vested tranches to 31-03-2027

ESOP extension

  • NRC extended the exercise period for the first tranche (250,000 options) to 31-03-2027.
  • Second tranche (125,000 options) exercise period extended to 31-03-2027.
  • Vesting dates and other terms under ESOP 2018 remain unchanged.
  • Extension approved by NRC via circular resolution dated 11 September 2026.
  • Total vested options affected amount to 375,000.
Filed 15:30View Source
26 Aug 20262 filings
Company UpdateClarification

The Exchange has sought clarification from Unichem Laboratories Ltd on August 26, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 14:03
Company UpdateSpurt in Volume

Significant increase in volume has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Unichem Laboratories Limited has submitted their response.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 09:18View Source
Showing 10 of 66 filings